Use of first-line chemotherapy for advanced pancreatic cancer: FOLFIRINOX versus gemcitabine.
Aimee Ginsburg Arlen
No relevant relationships to disclose
Thomas H. Cartwright
Consultant or Advisory Role - Amgen; Genentech; Lilly
Honoraria - Amgen; Genentech; Lilly
Lalan S. Wilfong
No relevant relationships to disclose
J. Russell Hoverman
Employment or Leadership Position - Texas Oncology; US Oncology
Consultant or Advisory Role - UnitedHealthcare
Greg C Nelson
No relevant relationships to disclose
Brian Turnwald
No relevant relationships to disclose
Roy A. Beveridge
Employment or Leadership Position - US Oncology
Honoraria - US Oncology